We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

8 hedge funds and large institutions have $799K invested in Intelligent Bio Solutions in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more capital invested

Capital invested by funds: $272K → $799K (+$527K)

0% less ownership

Funds ownership: 0%0% (-0%)

33% less funds holding

Funds holding: 128 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change

INBS Hedge Fund Activity: Q3 2022 in Review

8 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2022, worth a combined $799K — up 194% from $272K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of INBS and 3 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.2K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $22K sold.

  • 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2022, down from 12 in Q2 2022.
  • Funds reported $799K of Intelligent Bio Solutions stock for Q3 2022, up 194% quarter-over-quarter.
  • 3 funds opened new Intelligent Bio Solutions positions in Q3 2022 and 7 closed out, a net change of -4 holders.
  • The largest Intelligent Bio Solutions buyer in Q3 2022 was Citadel Advisors, an estimated $21.2K added.
  • The largest Intelligent Bio Solutions seller in Q3 2022 was Susquehanna International Group, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2022.